Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Related structures:
AlphaFold database: A0A3S7X5Y8
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 5 |
GO:0003824 | catalytic activity | 1 | 5 |
GO:0004518 | nuclease activity | 4 | 5 |
GO:0004527 | exonuclease activity | 5 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0016787 | hydrolase activity | 2 | 5 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 5 |
GO:0097159 | organic cyclic compound binding | 2 | 5 |
GO:1901363 | heterocyclic compound binding | 2 | 5 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.367 |
CLV_NRD_NRD_1 | 178 | 180 | PF00675 | 0.572 |
CLV_NRD_NRD_1 | 26 | 28 | PF00675 | 0.349 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.367 |
CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.572 |
CLV_PCSK_KEX2_1 | 26 | 28 | PF00082 | 0.349 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.557 |
DOC_PP4_FxxP_1 | 115 | 118 | PF00568 | 0.567 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.567 |
LIG_14-3-3_CanoR_1 | 26 | 35 | PF00244 | 0.567 |
LIG_CSL_BTD_1 | 115 | 118 | PF09270 | 0.567 |
LIG_deltaCOP1_diTrp_1 | 6 | 16 | PF00928 | 0.456 |
LIG_FHA_1 | 167 | 173 | PF00498 | 0.567 |
LIG_LIR_Gen_1 | 125 | 136 | PF02991 | 0.567 |
LIG_LIR_Gen_1 | 39 | 48 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 125 | 131 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 39 | 43 | PF02991 | 0.505 |
LIG_LYPXL_yS_3 | 133 | 136 | PF13949 | 0.567 |
LIG_NRBOX | 167 | 173 | PF00104 | 0.567 |
LIG_Pex14_1 | 116 | 120 | PF04695 | 0.567 |
LIG_Pex14_1 | 180 | 184 | PF04695 | 0.566 |
LIG_Pex14_2 | 98 | 102 | PF04695 | 0.505 |
LIG_SH2_CRK | 59 | 63 | PF00017 | 0.567 |
LIG_SH2_PTP2 | 19 | 22 | PF00017 | 0.567 |
LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.569 |
LIG_SH2_STAT6 | 111 | 115 | PF00017 | 0.567 |
LIG_SH3_1 | 19 | 25 | PF00018 | 0.567 |
LIG_SH3_2 | 22 | 27 | PF14604 | 0.567 |
LIG_SH3_3 | 115 | 121 | PF00018 | 0.517 |
LIG_SH3_3 | 128 | 134 | PF00018 | 0.546 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.505 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.567 |
LIG_TYR_ITIM | 131 | 136 | PF00017 | 0.567 |
LIG_TYR_ITIM | 57 | 62 | PF00017 | 0.567 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.511 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.340 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.305 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.537 |
MOD_N-GLC_1 | 94 | 99 | PF02516 | 0.367 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.505 |
MOD_PKA_1 | 178 | 184 | PF00069 | 0.584 |
MOD_PKA_1 | 26 | 32 | PF00069 | 0.567 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.460 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.505 |
MOD_Plk_1 | 164 | 170 | PF00069 | 0.567 |
MOD_Plk_1 | 94 | 100 | PF00069 | 0.517 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.488 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.567 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.528 |
TRG_ENDOCYTIC_2 | 133 | 136 | PF00928 | 0.559 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.567 |
TRG_ER_diArg_1 | 107 | 109 | PF00400 | 0.567 |
TRG_ER_diArg_1 | 178 | 180 | PF00400 | 0.543 |
TRG_ER_diArg_1 | 25 | 27 | PF00400 | 0.554 |